Industry S Science News
Europe’s summer heat wave killed more than 50,000 people in urban areas
Researchers estimate climate change is responsible for two-thirds of the deaths
Industry headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Industry S Science News
Researchers estimate climate change is responsible for two-thirds of the deaths
Industry P pharmaphorum
12 Questions with Julia Jakl Nicole.Raleigh Thu, 22/10/2026 - 07:00
Industry
BioSpace
The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the only program adjustment affecting foreign-born job seekers’ odds of working in the U.S.
Industry S Science News
Tam Dao, who investigated foreign attempts to obtain U.S.-funded research, now has a grant to determine the extent of the threat
Industry I In the Pipeline
I’m always glad to see articles like this one, where someone goes to the trouble of confirming whether “Compound X is a selective probe for Protein Target Y” is a true statement. That’s because it’s not all that easy to find a selective probe! A basic rule of small molecules in b…
Industry
BioCentury
BIOCENTURY | EMERGING COMPANY PROFILEAPTADIR: SWITCHING SILENCED GENES BACK ON WITH TARGETED DEMETHYLATIONMilan-based biotech raised a €40M seed round to take RNA-DNA chimeras into the clinic, starting with fragile X syndrome
Industry
BioCentury
BIOCENTURY | MANAGEMENT TRACKSCSL, VOYAGER INTRODUCE INCOMING CEOSAustralian biopharma taps ViiV’s Waterhouse; Swartz to succeed Sandrock at gene therapy company
Industry N Nature Reviews Bioengineering
Industry
Nature Biotechnology
Industry
Nature Biotechnology
Industry N Nature Medicine
Industry B BioPharm International
Sanofi breaks ground on an EU-backed insulin API plant in Frankfurt, Summit and ECOG-ACRIN launch a phase 2/3 trial of ivonescimab in first-line biliary tract cancer, and TaiMed’s anti-CD4 antibody TMB-365 lowers HIV viral load in phase 1.
Industry
MedTech Dive
Dr. Michelle Tarver said the FDA’s device center is filling positions after losing large numbers of clinical reviewers and AI and digital health experts.
Industry
MedTech Dive
Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.
Industry B BioPharm International
Rohit Tripathi, vice president of industry strategy, consumer packaged goods, and manufacturing at RELEX Solutions, explains what is driving biopharma reshoring, how USMCA uncertainty complicates sourcing for biologics, and where cold-chain visibility still breaks down.
Industry
Inside Precision Medicine
Researchers mapped the functional effects of more than 13,000 KCNQ1 variants, providing evidence to help distinguish disease-causing changes from benign variants in inherited long QT syndrome. The post Long QT Syndrome Risk Clarified by Functional Map of <i>KCNQ1</i>…
Industry
GEN
The results of a preclinical study suggest that the BCG vaccine, which is widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia by inducing trained immunity. The post BCG Vaccine-Induced Trained Immunity May Help…
Industry
GEN
Researchers also developed a clinical obesity polygenic score that combined information from numerous genetic variants, a score that was shown to be significantly associated with BMI, body fat percentage, and waist circumference. The post ASHG: Signals Based on Clinical Obesity S…
Industry
Drug Delivery Business
After claiming an FDA de novo nod in August, Abbott (NYSE: ABT) said it plans to launch its Libre Duo dual-analyte sensor in the U.S. this December. The roll out of the new continuous glucose monitor, which also tracks ketone levels to safeguard against diabetic ketoacidosis, wil…
Industry
Inside Precision Medicine
Tracking microscopic traces of cancer in the blood stream can identify patients whose cancer is at risk of returning, research suggests. The post Blood Test Identifies Residual Cancer appeared first on Inside Precision Medicine.
Industry
GEN
In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to understand patient tumor states and next-generation preclinical models that reproduce their biological complexity. The post Bridging the Translational Gap in…
Industry
STAT Biotech
In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care.
Industry P Pharmaceutical Commerce
CSafe's Aaron Mantia explains how lane, temperature range, duration and product cost shape thermal protection choices for bulk air cargo.
Industry
C&EN Pharmaceuticals
How Cas12a2 could provide a new way to fight cancer and other diseases
Industry
MedTech Dive
Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.
Industry
Fierce Pharma
Biopharma Companies Must Break the DMTA Linearity jpiatt Wed, 10/21/2026 - 12:17
Industry B BioPharm International
Dr Julie Gerberding and Dr David Berry will headline the October 25-28 New Orleans meeting, which adds a USP standards workshop and AI, organoid tracks.
Industry
GEN
Combining Raman and NIR spectroscopy into a single framework creates a multi-modal soft-sensing option that is effective for fed-batch, online, and in-line glucose sensing, preparing the way for hybrid/continuous processing. The post Raman+NIR Spectra Improves Glucose Soft Sensin…
Industry
Inside Precision Medicine
The Flagship Pioneering company’s all-RNA genome engineering platform can permanently inserts therapeutic genes and generates functional CAR T cells in vivo, addressing “copycat” criticism. The post With <i>In Vivo</i> ‘Gene Writers,’ Tessera Shows DNA Engineering Dif…
Industry
BioPharma Dive
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one analyst said.
Industry
Inside Precision Medicine
An early-phase trial found promising responses to firmonertinib in EGFR PACC-mutant NSCLC, highlighting how matching drug structure to mutation biology could expand targeted treatment options. The post Rare Structural Mutations in NSCLC Successfully Targeted appeared first on Ins…
Industry P pharmaphorum
Despite US policy changes, drug prices stay stubbornly high Phil.Taylor Wed, 21/10/2026 - 15:23
Industry
BioPharma Dive
New follow-up results suggest Arcus’ drug might be superior to a marketed Merck medicine. Elsewhere, Eli Lilly and AstraZeneca forged new partnerships.
Industry
GEN
In this GEN webinar, our expert speaker, Arati Naveen, PhD, will trace the foundational discoveries that shaped organoid technology as a new approach methodology (NAM), while highlighting pioneering contributions and contemporary advances. The post The Organoid Odyssey: A Glimpse…
Industry P Pharmaceutical Commerce
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.
Industry P Pharmaceutical Executive
Median net launch prices for new drugs climbed between 2022 and 2025 to $257,000, according to a new ICER and West Health report that also found persistent coverage and access barriers for patients.
Industry G GCBR Organization Updates
Updates from CLTR, Coefficient Giving, Mirror Biology Dialogues Fund, CSR, IGSC, Blueprint Biosecurity, FAI, and RAND CAST
Industry P PLOS Biology
by Huimin Liu, Yuzhen Wang, Ruiqing Yu, Kexin Liu, Dezhi Zheng, Bo Wang, Yuan Chang, Bing Liu, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Xiaohong Liang, Chunhong Ma, Guohua Liu, Jianhua Li, Leiqi Xu, Lifen Gao Macrophages play a pivotal role in the pathogenesis of inflammatory bow…
Industry P PLOS Biology
by Yi Qiu, Emilie Hebraud, Fanny Pouyet, Alexander F. Palazzo In the human genome, mutation rates vary along genes, yet how their fine-scale structure contributes to gene evolution has remained largely unexplored. Here, we map inherited mutations at single-nucleotide resolution a…
Industry
Clinical Trials Arena
The post Covid-19 and international aid cuts disrupt tuberculosis care in South Africa appeared first on Clinical Trials Arena.